• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种选择性的苯乙肼类似物抑制剂,可抑制组蛋白去甲基化酶 LSD1。

A selective phenelzine analogue inhibitor of histone demethylase LSD1.

机构信息

Department of Pharmacology, ∥Center for Epigenetics and Department of Medicine, ⊥Department of Ophthalmology, and ¶The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine , Baltimore, Maryland 21205, United States.

出版信息

ACS Chem Biol. 2014 Jun 20;9(6):1284-93. doi: 10.1021/cb500018s. Epub 2014 Apr 7.

DOI:10.1021/cb500018s
PMID:24707965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4076021/
Abstract

Lysine-specific demethylase 1 (LSD1) is an epigenetic enzyme that oxidatively cleaves methyl groups from monomethyl and dimethyl Lys4 of histone H3 (H3K4Me1, H3K4Me2) and can contribute to gene silencing. This study describes the design and synthesis of analogues of a monoamine oxidase antidepressant, phenelzine, and their LSD1 inhibitory properties. A novel phenelzine analogue (bizine) containing a phenyl-butyrylamide appendage was shown to be a potent LSD1 inhibitor in vitro and was selective versus monoamine oxidases A/B and the LSD1 homologue, LSD2. Bizine was found to be effective at modulating bulk histone methylation in cancer cells, and ChIP-seq experiments revealed a statistically significant overlap in the H3K4 methylation pattern of genes affected by bizine and those altered in LSD1-/- cells. Treatment of two cancer cell lines, LNCaP and H460, with bizine conferred a reduction in proliferation rate, and bizine showed additive to synergistic effects on cell growth when used in combination with two out of five HDAC inhibitors tested. Moreover, neurons exposed to oxidative stress were protected by the presence of bizine, suggesting potential applications in neurodegenerative disease.

摘要

赖氨酸特异性脱甲基酶 1(LSD1)是一种表观遗传酶,可氧化切割组蛋白 H3 上的单甲基和二甲基赖氨酸 4(H3K4Me1、H3K4Me2)上的甲基基团,有助于基因沉默。本研究描述了单胺氧化酶抗抑郁药苯乙肼类似物的设计和合成及其 LSD1 抑制特性。含有苯丁酰胺附肢的新型苯乙肼类似物(bizine)被证明是一种有效的 LSD1 抑制剂,对单胺氧化酶 A/B 和 LSD1 同源物 LSD2 具有选择性。Bizine 被发现可有效调节癌细胞中大量组蛋白甲基化,ChIP-seq 实验表明,受 bizine 影响的基因和 LSD1-/-细胞中改变的基因的 H3K4 甲基化模式存在统计学显著重叠。Bizine 处理两种癌细胞系 LNCaP 和 H460,可降低增殖率,与测试的五种 HDAC 抑制剂中的两种联合使用时,对细胞生长具有相加至协同作用。此外,暴露于氧化应激的神经元受到 bizine 的保护,这表明其在神经退行性疾病中有潜在的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/62b83e406fce/cb-2014-00018s_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/384ef4961a34/cb-2014-00018s_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/144420336c34/cb-2014-00018s_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/725c57939a47/cb-2014-00018s_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/b105da686417/cb-2014-00018s_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/af4d8ae03f2b/cb-2014-00018s_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/edcfdc03488e/cb-2014-00018s_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/62b83e406fce/cb-2014-00018s_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/384ef4961a34/cb-2014-00018s_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/144420336c34/cb-2014-00018s_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/725c57939a47/cb-2014-00018s_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/b105da686417/cb-2014-00018s_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/af4d8ae03f2b/cb-2014-00018s_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/edcfdc03488e/cb-2014-00018s_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c3/4076021/62b83e406fce/cb-2014-00018s_0007.jpg

相似文献

1
A selective phenelzine analogue inhibitor of histone demethylase LSD1.一种选择性的苯乙肼类似物抑制剂,可抑制组蛋白去甲基化酶 LSD1。
ACS Chem Biol. 2014 Jun 20;9(6):1284-93. doi: 10.1021/cb500018s. Epub 2014 Apr 7.
2
Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors.小分子和组蛋白底物类似物作为 LSD1 赖氨酸去甲基酶抑制剂的比较分析。
J Am Chem Soc. 2010 Mar 10;132(9):3164-76. doi: 10.1021/ja909996p.
3
Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).赖氨酸特异性去甲基化酶1和2(LSD1和LSD2)对组织因子途径抑制剂-2(TFPI-2)表达的调控
Biosci Biotechnol Biochem. 2014;78(6):1010-7. doi: 10.1080/09168451.2014.910104. Epub 2014 Jun 13.
4
Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.新型组蛋白 H3 肽基 LSD1 失活剂的设计、合成及体外评价,其中包含具有 γ-转角诱导结构的α,α-二取代氨基酸。
Molecules. 2018 May 6;23(5):1099. doi: 10.3390/molecules23051099.
5
The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.聚胺类似物赖氨酸特异性去甲基化酶-1(LSD1)抑制剂在人急性髓系白血病细胞系中重新表达表观遗传沉默的 E-钙黏蛋白基因。
Amino Acids. 2014 Mar;46(3):585-94. doi: 10.1007/s00726-013-1485-1. Epub 2013 Mar 19.
6
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.抑制赖氨酸特异性去甲基化酶1(LSD1)的药理学作用用于治疗混合系白血病重排(MLL-rearranged)白血病
J Hematol Oncol. 2016 Mar 12;9:24. doi: 10.1186/s13045-016-0252-7.
7
Structure activity relationship and modeling studies of inhibitors of lysine specific demethylase 1.赖氨酸特异性去甲基化酶1抑制剂的构效关系及建模研究
PLoS One. 2017 Feb 3;12(2):e0170301. doi: 10.1371/journal.pone.0170301. eCollection 2017.
8
Human histone demethylase LSD1 reads the histone code.人类组蛋白去甲基化酶LSD1解读组蛋白密码。
J Biol Chem. 2005 Dec 16;280(50):41360-5. doi: 10.1074/jbc.M509549200. Epub 2005 Oct 13.
9
Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.沉默 LSD1 基因可调节组蛋白甲基化和乙酰化,并诱导 JeKo-1 和 MOLT-4 细胞凋亡。
Int J Mol Med. 2017 Aug;40(2):319-328. doi: 10.3892/ijmm.2017.3032. Epub 2017 Jun 19.
10
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.抑制 LSD1 可增强胶质母细胞瘤细胞对组蛋白去乙酰化酶抑制剂的敏感性。
Neuro Oncol. 2011 Aug;13(8):894-903. doi: 10.1093/neuonc/nor049. Epub 2011 Jun 8.

引用本文的文献

1
CoREST in pieces: Dismantling the CoREST complex for cancer therapy and beyond.CoREST分解:为癌症治疗及其他领域拆解CoREST复合物
Sci Adv. 2025 Jun 6;11(23):eads6556. doi: 10.1126/sciadv.ads6556.
2
Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.泛素蛋白酶体系统(UPS):癌症表观遗传格局的关键决定因素。
Epigenomics. 2025 Jun;17(9):625-644. doi: 10.1080/17501911.2025.2501524. Epub 2025 May 8.
3
Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy.

本文引用的文献

1
Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.通过联合抑制癌细胞中的DNA甲基转移酶(DNMTs)和赖氨酸特异性去甲基化酶1(LSD1)对表观遗传沉默基因进行协同重新激活。
PLoS One. 2013 Sep 6;8(9):e75136. doi: 10.1371/journal.pone.0075136. eCollection 2013.
2
Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation.组蛋白去甲基化酶Lsd1在血细胞成熟过程中抑制造血干细胞和祖细胞特征。
Elife. 2013 Jun 18;2:e00633. doi: 10.7554/eLife.00633.
3
diffReps: detecting differential chromatin modification sites from ChIP-seq data with biological replicates.
发现用于非小细胞肺癌治疗的新型赖氨酸特异性去甲基化酶1/表皮生长因子受体双靶点抑制剂
Acta Pharmacol Sin. 2025 Apr;46(4):1030-1044. doi: 10.1038/s41401-024-01439-w. Epub 2025 Jan 3.
4
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy.组蛋白修饰在肿瘤发生中的作用以及癌症治疗中的相关抑制剂。
J Natl Cancer Cent. 2022 Sep 28;2(4):277-290. doi: 10.1016/j.jncc.2022.09.002. eCollection 2022 Dec.
5
Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1.通过工程化赖氨酸脱甲基酶LSD1来解开组蛋白修饰的串扰。
Nat Chem Biol. 2025 Feb;21(2):227-237. doi: 10.1038/s41589-024-01671-9. Epub 2024 Jul 4.
6
Aziridination via Nitrogen-Atom Transfer to Olefins from Photoexcited Azoxy-Triazenes.通过光激发的氧化偶氮三氮烯将氮原子转移至烯烃实现氮杂环丙烷化反应。
J Am Chem Soc. 2024 Apr 10;146(14):9499-9505. doi: 10.1021/jacs.3c14713. Epub 2024 Mar 24.
7
The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma.CoREST 抑制复合物介导黑色素瘤的表型转换和治疗抵抗。
J Clin Invest. 2024 Feb 1;134(6):e171063. doi: 10.1172/JCI171063.
8
Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies.赖氨酸特异性去甲基化酶1抑制剂:利用计算机辅助药物设计技术的综合综述
Molecules. 2024 Jan 22;29(2):550. doi: 10.3390/molecules29020550.
9
A histone demethylase links the loss of plasticity to nongenetic inheritance and morphological change.一种组蛋白去甲基化酶将可塑性的丧失与非遗传继承和形态变化联系起来。
Nat Commun. 2023 Dec 19;14(1):8439. doi: 10.1038/s41467-023-44306-8.
10
OVOL2 sustains postnatal thymic epithelial cell identity.OVOL2 维持产后胸腺上皮细胞的特性。
Nat Commun. 2023 Nov 27;14(1):7786. doi: 10.1038/s41467-023-43456-z.
diffReps:使用具有生物学重复的 ChIP-seq 数据检测差异染色质修饰位点。
PLoS One. 2013 Jun 10;8(6):e65598. doi: 10.1371/journal.pone.0065598. Print 2013.
4
Protein recognition by short peptide reversible inhibitors of the chromatin-modifying LSD1/CoREST lysine demethylase.短肽可逆抑制剂识别组蛋白修饰酶 LSD1/CoREST 的赖氨酸去甲基酶。
ACS Chem Biol. 2013 Aug 16;8(8):1677-82. doi: 10.1021/cb4001926. Epub 2013 Jun 11.
5
Synthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties.合成及评价 3-氨基/胍基取代苯并恶唑作为一类新型 LSD1 抑制剂的抗增殖活性。
Org Biomol Chem. 2013 May 21;11(19):3103-7. doi: 10.1039/c3ob40217g. Epub 2013 Apr 10.
6
The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.聚胺类似物赖氨酸特异性去甲基化酶-1(LSD1)抑制剂在人急性髓系白血病细胞系中重新表达表观遗传沉默的 E-钙黏蛋白基因。
Amino Acids. 2014 Mar;46(3):585-94. doi: 10.1007/s00726-013-1485-1. Epub 2013 Mar 19.
7
Structure-function analysis reveals a novel mechanism for regulation of histone demethylase LSD2/AOF1/KDM1b.结构-功能分析揭示了组蛋白去甲基酶 LSD2/AOF1/KDM1b 调控的新机制。
Cell Res. 2013 Feb;23(2):225-41. doi: 10.1038/cr.2012.177. Epub 2012 Dec 25.
8
Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.LSD1(赖氨酸特异性去甲基化酶 1)的缺失以 p53 和 DNMT1(DNA 甲基转移酶 1)非依赖的方式抑制人结肠癌细胞的生长并改变其基因表达。
Biochem J. 2013 Jan 15;449(2):459-68. doi: 10.1042/BJ20121360.
9
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.作为赖氨酸特异性去甲基酶 1 的有效抑制剂的低分子量酰亚胺肟。
J Med Chem. 2012 Sep 13;55(17):7378-91. doi: 10.1021/jm3002845. Epub 2012 Sep 4.
10
Brain-penetrant LSD1 inhibitors can block memory consolidation.可穿透血脑屏障的赖氨酸特异性去甲基化酶1(LSD1)抑制剂能够阻断记忆巩固。
ACS Chem Neurosci. 2012 Feb 15;3(2):120-128. doi: 10.1021/cn200104y. Epub 2011 Oct 18.